 |
Sector: Pharmaceuticals. Activities: Research, development, production and marketing of pharmaceuticals. Status: Full. Market Cap: (31 Oct 03) £47,118m. P&L: (31 Dec 02) Turnover £11,082m, pretax £2,508m. Ord Capital: (31 Dec 02) 1,716m US$0.25 Ords. (29 Jan 03) Capital Grp Co’s Inc 11.9%, Investor AB 5.33%, Putnam Inv Mgmt LLC 3.07%, Legal & General Inv Mgmt Ltd 3.06%, Dirs 0.03%. Registrars: Lloyds TSB Registrars, Worthing. Tel: (0870) 600 3964. Executive Directors: McKillop, Sir Thomas Fulton Wilson ( Tom), BSc PhD; app Jan 96, (Chief Executive), (78,402 Ords; 453,242 Incentive shrs). Symonds, Jonathan R; app Oct 97, (Chief Financial Officer), (10,929 Ords; 208,388 Incentive shrs). Non-Executive Directors: Barnevik, Percy; app Apr 99, (Chairman), (50,000 Ords); Mogren, Dr Hakan L, DSc; app Apr 99, (Deputy Chairman), (62,164 Ords; 269,976 Incentive shrs); Bonfield, Sir Peter Leahy, CBE CBI FREng FIEE FBCS FCIM CIMgt [Rem]; app Jan 95, (500 Ords); Ogilvie, Dame Bridget M, ScD FIBiol FRCPath [Aud]; app Jan 97, (500 Ords); von der Heyden, Karl M [Aud]; app Oct 98, (20,000 Ords); Moller, Erna, MD PhD DMed [Rem]; app Apr 99, (2,718 Ords); Wallenberg, Marcus [Aud]; app Apr 99, (74,504 Ords); Henney, Jane E, MD [Aud]; app Sep 01, (500 Ords); Buchanan, Dr John G S, PhD [Rem, Aud]; app Apr 02, (500 Ords). Hooper, Michelle; app Jul 03, (500 Ords); Jimenez, Joe; app Jul 03(500 Ords). Company Secretary: Musker, Graeme H R. Dirs Pay: (31 Dec 02) Total (incl pension costs) £5.37m (£5.12m); Ave overall £383,643 (£365,929); Ave higher paid £412,192 (£393,500). CH (excl pension conts) £231,691 (£250,240); HPD £1,371,514 (£1,304,240). Employees: (31 Dec 02) 57,500 (52,600). Total pay £2,480m (£2,435m); Ave pay £43,135 (£46,293). Bankers: Citibank; HSBC Bank PLC. Fin Advisers: Credit Suisse First Boston; Merrill Lynch. Brokers: Credit Suisse First Boston (Europe) Ltd; Merrill Lynch International. Auditors: KPMG. Solicitors: Freshfields Bruckhaus Deringer; Mayer, Brown, Rowe & Maw; Field Fisher Waterhouse. Fin PR: Brunswick |
|
Companies
in Focus • Focus Features
• Compilation •
Search & Selection •
Contact Us • Subscribtion
Offer
• About the Brand Corporate
Register
ADVICE TO READERS While this website is checked for accuracy, we are not liable for any incorrect information included. We recommend that you make enquiries based on your own circumstances and, if necessary, take professional advice before entering into transactions. other
sites in the group |